Skip to content

Group A Strep Vaccine Study

Healthy Volunteers | Vaccine

The purpose of this study is to investigate the safety and antibody (germ fighters) response of experimental (investigational) vaccines against the group A streptococcus when injected into the arm of healthy adults. Approximately 37 participants in Edmonton, Alberta will participate in the study.

null

Conditions de participation

  • Sexe:

    Any
  • Âges admissibles:

    18 to 45

Critères de participation

Inclusion Criteria:
-Healthy Participants 18-45 inclusive
-Non Smoker
-Intention to reside within the Edmonton area for a 10 month period
-Agree not to participate in any other clinical trial during the trial
-Agree not to donate blood for the duration of the trial
Exclusion Criteria:
-Personal or family history of post-streptococcal disease (rheumatic fever or glomerulonephritis), or collagen-vascular disease
-Presence of significant acute infection requiring systemic antibiotic treatment within the 14 days prior to each product administration;
-Pregnant or breast feeding (all women will have a negative pregnancy test result prior to each study product administered);
-Immunized or intent to immunize with any vaccine or investigational agents within 30 days prior to enrolment through to 30 days following the last study vaccine administration, with the exception of licensed inactivated influenza vaccines and COVID-19 vaccines
-Past significant reaction following any previous vaccination;

Lieu de l'étude

University of Alberta
University of Alberta
Edmonton, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Ijeoma Ogbuehi

[email protected]
5879826635
Étude parrainée par
University of Alberta
Participants recherchés
Plus d'informations
ID de l'étude: Pro00089919